{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index([u'COUNTRY', u'PUB_ID', u'APPL_ID', u'SUMMARY', u'ABSTRACT'], dtype='object')"
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import math\n",
    "from sklearn.utils import shuffle\n",
    "import csv\n",
    "\n",
    "df_all = pd.read_csv('patent_data_2wks.csv')  # use this for running with small data\n",
    "df_all = df_all[df_all['ABSTRACT'].notnull()]\n",
    "df_all = df_all[df_all['APPL_ID'].notnull()]\n",
    "\n",
    "df_all.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df_all = df_all.drop_duplicates(subset=[ 'ABSTRACT'], keep=False)\n",
    "\n",
    "df_all = df_all[:1000] #this will process only forst 1000 records, comment this if you want to run on all 7000 records"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def cosine_similarity(vector1, vector2):\n",
    "    dot_product = sum(p*q for p,q in zip(vector1, vector2))\n",
    "    magnitude = math.sqrt(sum([val**2 for val in vector1])) * math.sqrt(sum([val**2 for val in vector2]))\n",
    "    if not magnitude:\n",
    "        return 0\n",
    "    return dot_product/magnitude"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from sklearn.feature_extraction import text\n",
    "\n",
    "my_words = ['','()','(),']\n",
    "my_stop_words = text.ENGLISH_STOP_WORDS.union(my_words)\n",
    "\n",
    "tokenize = lambda doc: doc.lower().split(\" \")\n",
    " \n",
    "sklearn_tfidf = TfidfVectorizer(norm='l2',min_df=0, use_idf=True, smooth_idf=False, sublinear_tf=True,\n",
    "                                stop_words=set(my_stop_words),\n",
    "                                max_features = 200, tokenizer=tokenize)\n",
    "sklearn_representation = sklearn_tfidf.fit_transform(df_all['ABSTRACT'])\n",
    "\n",
    "#print sklearn_tfidf.get_feature_names()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------------------\n",
      "1.0 , 15065288 , 15065304\n",
      "The present invention is in the field of soybean variety SJ1312299 breeding and development. The present invention particularly relates to the soybean variety SJ1312299 and its seed, cells, germplasm, plant parts, and progeny, and methods of using SJ1312299 in a breeding program.\n",
      "\n",
      "The present invention is in the field of soybean variety SJ1312462 breeding and development. The present invention particularly relates to the soybean variety SJ1312462 and its seed, cells, germplasm, plant parts, and progeny, and methods of using SJ1312462 in a breeding program.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "1.0 , 15065304 , 15065288\n",
      "The present invention is in the field of soybean variety SJ1312462 breeding and development. The present invention particularly relates to the soybean variety SJ1312462 and its seed, cells, germplasm, plant parts, and progeny, and methods of using SJ1312462 in a breeding program.\n",
      "\n",
      "The present invention is in the field of soybean variety SJ1312299 breeding and development. The present invention particularly relates to the soybean variety SJ1312299 and its seed, cells, germplasm, plant parts, and progeny, and methods of using SJ1312299 in a breeding program.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.936303825935 , 15395540 , 15395608\n",
      "Described herein is a cosmetic system for applying a cosmetic composition including a cosmetic applicator and a cosmetic composition, where the cosmetic applicator includes a container configured to store the cosmetic composition, an applicator head having a non-linear shape with a proximal end and a distal end, and a slit along an axis of the applicator head, the distal end connected to the container.\n",
      "\n",
      "Described herein is a cosmetic system for applying a cosmetic composition including a cosmetic applicator and a cosmetic composition, where the cosmetic applicator includes includes a container configured to store the cosmetic composition, an applicator head having a linear or non-linear shape with a proximal end and a distal end, and a plurality of holes along or around the circumference of the applicator head, the distal end connected to the container.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.936303825935 , 15395608 , 15395540\n",
      "Described herein is a cosmetic system for applying a cosmetic composition including a cosmetic applicator and a cosmetic composition, where the cosmetic applicator includes includes a container configured to store the cosmetic composition, an applicator head having a linear or non-linear shape with a proximal end and a distal end, and a plurality of holes along or around the circumference of the applicator head, the distal end connected to the container.\n",
      "\n",
      "Described herein is a cosmetic system for applying a cosmetic composition including a cosmetic applicator and a cosmetic composition, where the cosmetic applicator includes a container configured to store the cosmetic composition, an applicator head having a non-linear shape with a proximal end and a distal end, and a slit along an axis of the applicator head, the distal end connected to the container.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.968411352317 , 15605959 , 15605960\n",
      "A bedhead and a collapsible bed frame with the bedhead are provided. The bedhead includes at least two unitary frames. Each unitary frame has at least one storage room at a back thereof. After the collapsible bed frame is disassembled, it can be accommodated in the storage room of the bedhead. For transportation, the parts of the bed frame are accommodated in the storage room of the bedhead, and the unitary frames of the bedhead are folded to form a box. The volume of the bed frame and the bedhead after folded is reduced greatly to be transported and stored conveniently.\n",
      "\n",
      "A bedhead and a collapsible bed frame with the bedhead are provided. The bedhead includes at least two unitary frames. Each unitary frame has at least one storage room at a back thereof After the collapsible bed frame is disassembled, it can be accommodated in the storage room of the bedhead. For transportation, the parts of the bed frame are accommodated in the storage room of the bedhead, and the unitary frames of the bedhead are folded to form a box. The volume of the bed frame and the bedhead after folded is reduced greatly to be transported and stored conveniently.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.968411352317 , 15605960 , 15605959\n",
      "A bedhead and a collapsible bed frame with the bedhead are provided. The bedhead includes at least two unitary frames. Each unitary frame has at least one storage room at a back thereof After the collapsible bed frame is disassembled, it can be accommodated in the storage room of the bedhead. For transportation, the parts of the bed frame are accommodated in the storage room of the bedhead, and the unitary frames of the bedhead are folded to form a box. The volume of the bed frame and the bedhead after folded is reduced greatly to be transported and stored conveniently.\n",
      "\n",
      "A bedhead and a collapsible bed frame with the bedhead are provided. The bedhead includes at least two unitary frames. Each unitary frame has at least one storage room at a back thereof. After the collapsible bed frame is disassembled, it can be accommodated in the storage room of the bedhead. For transportation, the parts of the bed frame are accommodated in the storage room of the bedhead, and the unitary frames of the bedhead are folded to form a box. The volume of the bed frame and the bedhead after folded is reduced greatly to be transported and stored conveniently.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.904834593725 , 15363565 , 15065232\n",
      "A dishwasher can comprise a tub to define a treating chamber in which articles are treated according to a cycle of operation. The treating chamber can have an access opening with a cover selectively permitting access to the treating chamber. A condenser assembly can fluidly couple to the treating chamber for drying articles washed during the cycler of operation. The condenser can fluidly couple to an exhaust conduit disposed in a toe kick panel, which attenuates the sound travelling through the toe kick panel.\n",
      "\n",
      "A dishwasher can comprise a tub to at least define a treating chamber. The treating chamber can have an access opening with a cover selectively permitting access to the treating chamber. The condenser assembly can be made of a multi-layer absorptive acoustic material, which attenuates sound emanating from the treating chamber and travelling through the condensing section. The sounds attenuation can provide for reducing or eliminating the need for sound insulation necessary within the dishwasher.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.904834593725 , 15065232 , 15363565\n",
      "A dishwasher can comprise a tub to at least define a treating chamber. The treating chamber can have an access opening with a cover selectively permitting access to the treating chamber. The condenser assembly can be made of a multi-layer absorptive acoustic material, which attenuates sound emanating from the treating chamber and travelling through the condensing section. The sounds attenuation can provide for reducing or eliminating the need for sound insulation necessary within the dishwasher.\n",
      "\n",
      "A dishwasher can comprise a tub to define a treating chamber in which articles are treated according to a cycle of operation. The treating chamber can have an access opening with a cover selectively permitting access to the treating chamber. A condenser assembly can fluidly couple to the treating chamber for drying articles washed during the cycler of operation. The condenser can fluidly couple to an exhaust conduit disposed in a toe kick panel, which attenuates the sound travelling through the toe kick panel.\n",
      "----------------------------------------------------\n",
      "Processed records: 500\n",
      "----------------------------------------------------\n",
      "0.945113413698 , 15168731 , 15067401\n",
      "A device comprising a casing and having an initial configuration, an intermediate configuration, and a final configuration, wherein in the initial configuration the casing contains: a plurality of beads, a rupturable first container containing one or more isocyanates and a rupturable second container containing one or more polyols. In the final configuration the casing is substantially filled by a polyurethane in which the plurality of beads is embedded. In the intermediate configuration the device is transformed from the initial configuration to the final configuration by rupturing the first container and rupturing the second container so that the one or more isocyanates react with the one or more polyols in a reaction that forms the polyurethane. As the polyurethane is formed during the reaction the polyurethane surrounds the plurality of beads. The casing includes one or more vent tubes configured to allow gases formed by the reaction to escape the casing.\n",
      "\n",
      "In an initial configuration a device comprises a casing containing: a plurality of beads, a rupturable first container containing one or more isocyanates and a rupturable second container containing one or more polyols, wherein in the final configuration the casing is substantially filled by a polyurethane in which the plurality of beads are embedded. In an intermediate configuration the device is transformed from the initial configuration to a final configuration by rupturing the first container and rupturing the second container so that the one or more isocyanates react with the one or more polyols in a reaction that forms the polyurethane. As the polyurethane is formed during the reaction the polyurethane surrounds the plurality of beads. The device may be molded as the polyurethane is formed in the casing.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.928080895741 , 15064233 , 15064252\n",
      "A segmented limb heater system method for controlled therapeutic heating of a limb having different segments and joints, differentially heating different segments or joints of a limb, with safe, automatic controls based on sensing of the different actual temperatures, in a portable, easy to use embodiment.\n",
      "\n",
      "A segmented limb heater system apparatus for controlled therapeutic heating of a limb having different segments and joints, differentially heating different segments or joints of a limb, with safe, automatic controls based on sensing of the different actual temperatures, in a portable, easy to use embodiment.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.928080895741 , 15064252 , 15064233\n",
      "A segmented limb heater system apparatus for controlled therapeutic heating of a limb having different segments and joints, differentially heating different segments or joints of a limb, with safe, automatic controls based on sensing of the different actual temperatures, in a portable, easy to use embodiment.\n",
      "\n",
      "A segmented limb heater system method for controlled therapeutic heating of a limb having different segments and joints, differentially heating different segments or joints of a limb, with safe, automatic controls based on sensing of the different actual temperatures, in a portable, easy to use embodiment.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.945113413698 , 15067401 , 15168731\n",
      "In an initial configuration a device comprises a casing containing: a plurality of beads, a rupturable first container containing one or more isocyanates and a rupturable second container containing one or more polyols, wherein in the final configuration the casing is substantially filled by a polyurethane in which the plurality of beads are embedded. In an intermediate configuration the device is transformed from the initial configuration to a final configuration by rupturing the first container and rupturing the second container so that the one or more isocyanates react with the one or more polyols in a reaction that forms the polyurethane. As the polyurethane is formed during the reaction the polyurethane surrounds the plurality of beads. The device may be molded as the polyurethane is formed in the casing.\n",
      "\n",
      "A device comprising a casing and having an initial configuration, an intermediate configuration, and a final configuration, wherein in the initial configuration the casing contains: a plurality of beads, a rupturable first container containing one or more isocyanates and a rupturable second container containing one or more polyols. In the final configuration the casing is substantially filled by a polyurethane in which the plurality of beads is embedded. In the intermediate configuration the device is transformed from the initial configuration to the final configuration by rupturing the first container and rupturing the second container so that the one or more isocyanates react with the one or more polyols in a reaction that forms the polyurethane. As the polyurethane is formed during the reaction the polyurethane surrounds the plurality of beads. The casing includes one or more vent tubes configured to allow gases formed by the reaction to escape the casing.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.959633086865 , 15529102 , 15529106\n",
      "The present invention relates to a pharmaceutical composition comprising the combination of (i) at least one biocompatible nanoparticle and (ii) at least one pharmaceutical compound, to be administered to a subject in need of such a pharmaceutical compound, wherein the nanoparticle potentiates the pharmaceutical compound efficiency. The longest dimension of the biocompatible nanoparticle is typically between about 4 and about 500 nm, its absolute surface charge value is of at least 10 mV (|10 mV|), and its Young modulus is less than 100 kPa. The invention also relates to such a composition for use for administering the pharmaceutical compound in a subject in need thereof, wherein the at least one nanoparticle and the at least one pharmaceutical compound are to be administered in the subject between more than 5 minutes and about 72 hours one from each other.\n",
      "\n",
      "The present invention relates to a pharmaceutical composition comprising the combination of (i) at least one biocompatible nanoparticle and (ii) at least one carrier comprising at least one pharmaceutical compound, to be administered to a subject in need of such a pharmaceutical compound, wherein the combination of the at least one biocompatible nanoparticle and of the at least one carrier comprising the pharmaceutical compound(s) potentiates the compound(s) of interest efficiency. The longest dimension of the biocompatible nanoparticle is typically between about 4 and about 500 nm and its absolute surface charge value is of at least 10 mV (|10 mV|). The carrier is in addition devoid of any surface sterically stabilizing agent. The invention also relates to such a composition for use for administering the pharmaceutical compound(s) in a subject in need thereof, wherein the at least one biocompatible nanoparticle and the at least one carrier comprising the at least one pharmaceutical compound are to be administered separately in a subject in need of said pharmaceutical compound, typically between more than 5 minutes and about 72 hours one from each other.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.959633086865 , 15529106 , 15529102\n",
      "The present invention relates to a pharmaceutical composition comprising the combination of (i) at least one biocompatible nanoparticle and (ii) at least one carrier comprising at least one pharmaceutical compound, to be administered to a subject in need of such a pharmaceutical compound, wherein the combination of the at least one biocompatible nanoparticle and of the at least one carrier comprising the pharmaceutical compound(s) potentiates the compound(s) of interest efficiency. The longest dimension of the biocompatible nanoparticle is typically between about 4 and about 500 nm and its absolute surface charge value is of at least 10 mV (|10 mV|). The carrier is in addition devoid of any surface sterically stabilizing agent. The invention also relates to such a composition for use for administering the pharmaceutical compound(s) in a subject in need thereof, wherein the at least one biocompatible nanoparticle and the at least one carrier comprising the at least one pharmaceutical compound are to be administered separately in a subject in need of said pharmaceutical compound, typically between more than 5 minutes and about 72 hours one from each other.\n",
      "\n",
      "The present invention relates to a pharmaceutical composition comprising the combination of (i) at least one biocompatible nanoparticle and (ii) at least one pharmaceutical compound, to be administered to a subject in need of such a pharmaceutical compound, wherein the nanoparticle potentiates the pharmaceutical compound efficiency. The longest dimension of the biocompatible nanoparticle is typically between about 4 and about 500 nm, its absolute surface charge value is of at least 10 mV (|10 mV|), and its Young modulus is less than 100 kPa. The invention also relates to such a composition for use for administering the pharmaceutical compound in a subject in need thereof, wherein the at least one nanoparticle and the at least one pharmaceutical compound are to be administered in the subject between more than 5 minutes and about 72 hours one from each other.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "1.0 , 15529607 , 15529606\n",
      "The invention relates to the treatment of actinic keratosis on the scalp with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).\n",
      "\n",
      "The invention relates to the treatment of actinic keratosis on the trunk (except chest) and extremities with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "1.0 , 15529607 , 15529631\n",
      "The invention relates to the treatment of actinic keratosis on the scalp with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).\n",
      "\n",
      "The invention relates to the treatment of actinic keratosis on the full face or 250 cmon the chest with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "1.0 , 15529606 , 15529607\n",
      "The invention relates to the treatment of actinic keratosis on the trunk (except chest) and extremities with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).\n",
      "\n",
      "The invention relates to the treatment of actinic keratosis on the scalp with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "1.0 , 15529606 , 15529631\n",
      "The invention relates to the treatment of actinic keratosis on the trunk (except chest) and extremities with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).\n",
      "\n",
      "The invention relates to the treatment of actinic keratosis on the full face or 250 cmon the chest with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "1.0 , 15529631 , 15529607\n",
      "The invention relates to the treatment of actinic keratosis on the full face or 250 cmon the chest with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).\n",
      "\n",
      "The invention relates to the treatment of actinic keratosis on the scalp with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "1.0 , 15529631 , 15529606\n",
      "The invention relates to the treatment of actinic keratosis on the full face or 250 cmon the chest with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).\n",
      "\n",
      "The invention relates to the treatment of actinic keratosis on the trunk (except chest) and extremities with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "1.0 , 15498554 , 15498556\n",
      "The present invention relates to genetically stable replication competent Sendai virus vector(s) containing optimized HIV genes, methods for making the same and cell substrates qualified for vaccine production which may comprise genetically stable replication competent Sendai virus vector(s) containing optimized HIV genes.\n",
      "\n",
      "The present invention relates to a vector(s) containing and expressing an optimized HIV EnvF gene, methods for making the same and cell substrates qualified for vaccine production which may comprise vector(s) containing optimized HIV genes.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "1.0 , 15498556 , 15498554\n",
      "The present invention relates to a vector(s) containing and expressing an optimized HIV EnvF gene, methods for making the same and cell substrates qualified for vaccine production which may comprise vector(s) containing optimized HIV genes.\n",
      "\n",
      "The present invention relates to genetically stable replication competent Sendai virus vector(s) containing optimized HIV genes, methods for making the same and cell substrates qualified for vaccine production which may comprise genetically stable replication competent Sendai virus vector(s) containing optimized HIV genes.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.994466289093 , 15421694 , 15421752\n",
      "In one embodiment, a confectionary comprises 50 to 75 wt. % erythritol, 0 to 75 wt. % of at least one additional sweetener, at least one stabilizer, water, and a first active ingredient. The water may comprise 0.5 to 3 wt. % of the confectionary. The water may have a water activity of from 0.3 to 0.5. The confectionary may be aerated such that the density of the confectionary is 0.05 to 0.3 grams per cubic centimeter.\n",
      "\n",
      "In one embodiment, a confectionary comprises at least one sweetener, at least one stabilizer, at least one emulsifier, water, a first active ingredient, and an enrobing layer. The water may comprise 2 to 20 wt. % of the confectionary. The confectionary may have a water activity of from 0.45 to 0.65. The confectionary may be aerated such that the density of the confectionary is 0.7 to 1.25 grams per cubic centimeter. The confectionary may have a pH of 5.0 to 8.0.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.994466289093 , 15421752 , 15421694\n",
      "In one embodiment, a confectionary comprises at least one sweetener, at least one stabilizer, at least one emulsifier, water, a first active ingredient, and an enrobing layer. The water may comprise 2 to 20 wt. % of the confectionary. The confectionary may have a water activity of from 0.45 to 0.65. The confectionary may be aerated such that the density of the confectionary is 0.7 to 1.25 grams per cubic centimeter. The confectionary may have a pH of 5.0 to 8.0.\n",
      "\n",
      "In one embodiment, a confectionary comprises 50 to 75 wt. % erythritol, 0 to 75 wt. % of at least one additional sweetener, at least one stabilizer, water, and a first active ingredient. The water may comprise 0.5 to 3 wt. % of the confectionary. The water may have a water activity of from 0.3 to 0.5. The confectionary may be aerated such that the density of the confectionary is 0.05 to 0.3 grams per cubic centimeter.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.975704982491 , 15509029 , 15509111\n",
      "A medical dressing is disclosed, comprising a substrate comprising a first chemical compound, said substrate having a first surface, wherein said medical dressing further comprises an adhesive layer having a skin-facing surface to adhere said medical dressing to a dermal surface, wherein at least a portion of said skin-facing surface comprises a coating comprising a second chemical compound. Also disclosed is a method of manufacturing such a medical dressing.\n",
      "\n",
      "A medical dressing () is disclosed, comprising an adhesive layer () having a skin-facing surface () to adhere the medical dressing to a dermal surface, wherein said adhesive layer comprises a first chemical compound incorporated within said adhesive layer, and wherein at least a portion of said skin-facing surface comprises a coating () comprising a second chemical compound. Also disclosed is a method of manufacturing such a medical dressing.\n",
      "----------------------------------------------------\n",
      "----------------------------------------------------\n",
      "0.975704982491 , 15509111 , 15509029\n",
      "A medical dressing () is disclosed, comprising an adhesive layer () having a skin-facing surface () to adhere the medical dressing to a dermal surface, wherein said adhesive layer comprises a first chemical compound incorporated within said adhesive layer, and wherein at least a portion of said skin-facing surface comprises a coating () comprising a second chemical compound. Also disclosed is a method of manufacturing such a medical dressing.\n",
      "\n",
      "A medical dressing is disclosed, comprising a substrate comprising a first chemical compound, said substrate having a first surface, wherein said medical dressing further comprises an adhesive layer having a skin-facing surface to adhere said medical dressing to a dermal surface, wherein at least a portion of said skin-facing surface comprises a coating comprising a second chemical compound. Also disclosed is a method of manufacturing such a medical dressing.\n",
      "----------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "threshold = 0.9\n",
    "for index_0, patent_0 in enumerate(sklearn_representation.toarray()):\n",
    "    for index_1, patent_1 in enumerate(sklearn_representation.toarray()):\n",
    "        cosine_sim = cosine_similarity(patent_0, patent_1)\n",
    "        if index_0 <> index_1 and cosine_sim > threshold:\n",
    "#             print cosine_sim, ',', df_all.iloc[index_0]['APPL_ID'],  ',', df_all.iloc[index_1]['APPL_ID']\n",
    "            print '----------------------------------------------------'\n",
    "            print cosine_sim, ',', df_all.iloc[index_0]['APPL_ID'],  ',', df_all.iloc[index_1]['APPL_ID']\n",
    "            print df_all.iloc[index_0]['ABSTRACT']\n",
    "            print \n",
    "            print df_all.iloc[index_1]['ABSTRACT']\n",
    "            print '----------------------------------------------------'\n",
    "            \n",
    "    if index_0 > 0 and index_0  % 500 == 0:\n",
    "        print 'Processed records:', index_0\n",
    "            "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "anaconda-cloud": {},
  "kernelspec": {
   "display_name": "Python [conda root]",
   "language": "python",
   "name": "conda-root-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
